| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 329 | 2024 | 12807 | 8.990 |
Why?
|
| Genetic Predisposition to Disease | 365 | 2025 | 18071 | 8.000 |
Why?
|
| Polymorphism, Single Nucleotide | 402 | 2024 | 16047 | 7.330 |
Why?
|
| Breast Neoplasms | 184 | 2025 | 21056 | 4.640 |
Why?
|
| Models, Genetic | 59 | 2021 | 3448 | 3.940 |
Why?
|
| Case-Control Studies | 258 | 2024 | 22222 | 2.970 |
Why?
|
| Genetic Variation | 78 | 2024 | 6610 | 2.950 |
Why?
|
| Prostatic Neoplasms | 98 | 2023 | 11083 | 2.900 |
Why?
|
| Genetic Loci | 60 | 2024 | 2631 | 2.850 |
Why?
|
| Pancreatic Neoplasms | 55 | 2024 | 5444 | 2.590 |
Why?
|
| Genotype | 171 | 2024 | 13024 | 2.530 |
Why?
|
| Multifactorial Inheritance | 30 | 2024 | 1425 | 2.410 |
Why?
|
| Quantitative Trait Loci | 45 | 2023 | 2140 | 2.370 |
Why?
|
| Linkage Disequilibrium | 55 | 2022 | 1997 | 1.910 |
Why?
|
| Mendelian Randomization Analysis | 30 | 2023 | 1044 | 1.770 |
Why?
|
| Quantitative Trait, Heritable | 10 | 2020 | 541 | 1.660 |
Why?
|
| Risk Factors | 235 | 2025 | 74836 | 1.570 |
Why?
|
| Chromosome Mapping | 39 | 2022 | 4618 | 1.460 |
Why?
|
| Alleles | 65 | 2023 | 6897 | 1.370 |
Why?
|
| Genome, Human | 42 | 2022 | 4448 | 1.330 |
Why?
|
| Humans | 690 | 2025 | 765956 | 1.310 |
Why?
|
| Female | 464 | 2025 | 396101 | 1.250 |
Why?
|
| Vitamin D | 22 | 2020 | 3272 | 1.240 |
Why?
|
| Haplotypes | 36 | 2022 | 2728 | 1.210 |
Why?
|
| Glaucoma, Open-Angle | 13 | 2024 | 742 | 1.210 |
Why?
|
| Receptors, Estrogen | 29 | 2023 | 2242 | 1.190 |
Why?
|
| Models, Statistical | 21 | 2020 | 5089 | 1.180 |
Why?
|
| Endometrial Neoplasms | 15 | 2023 | 1378 | 1.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 38 | 2023 | 12240 | 1.140 |
Why?
|
| Germ-Line Mutation | 17 | 2025 | 1884 | 1.110 |
Why?
|
| Genes | 6 | 2015 | 1825 | 1.100 |
Why?
|
| Middle Aged | 293 | 2025 | 223004 | 1.040 |
Why?
|
| Risk | 61 | 2023 | 9591 | 1.020 |
Why?
|
| Body Mass Index | 54 | 2023 | 13039 | 1.020 |
Why?
|
| Gene Frequency | 38 | 2024 | 3624 | 1.010 |
Why?
|
| Telomere | 11 | 2019 | 943 | 0.990 |
Why?
|
| Environment | 8 | 2015 | 1114 | 0.970 |
Why?
|
| Odds Ratio | 62 | 2024 | 9649 | 0.950 |
Why?
|
| ABO Blood-Group System | 11 | 2023 | 380 | 0.950 |
Why?
|
| Genetic Markers | 19 | 2018 | 2601 | 0.950 |
Why?
|
| Ovarian Neoplasms | 18 | 2023 | 4900 | 0.920 |
Why?
|
| BRCA1 Protein | 12 | 2023 | 1153 | 0.900 |
Why?
|
| Aged | 213 | 2025 | 171114 | 0.850 |
Why?
|
| Male | 324 | 2025 | 363691 | 0.850 |
Why?
|
| Smoking | 30 | 2021 | 9081 | 0.830 |
Why?
|
| Carcinoma, Pancreatic Ductal | 8 | 2023 | 1758 | 0.830 |
Why?
|
| Genomics | 23 | 2022 | 5929 | 0.820 |
Why?
|
| Fatty Acid Desaturases | 4 | 2018 | 102 | 0.810 |
Why?
|
| Risk Assessment | 60 | 2024 | 24283 | 0.800 |
Why?
|
| Genetic Association Studies | 28 | 2021 | 2741 | 0.800 |
Why?
|
| Body Height | 11 | 2022 | 1562 | 0.790 |
Why?
|
| Computer Simulation | 18 | 2021 | 6255 | 0.760 |
Why?
|
| Menarche | 9 | 2024 | 532 | 0.740 |
Why?
|
| Venous Thromboembolism | 11 | 2024 | 1882 | 0.740 |
Why?
|
| Genetic Testing | 17 | 2023 | 3595 | 0.740 |
Why?
|
| Germ Cells | 7 | 2023 | 647 | 0.730 |
Why?
|
| Insulin-Like Growth Factor I | 12 | 2017 | 1936 | 0.720 |
Why?
|
| Phenotype | 58 | 2022 | 16721 | 0.700 |
Why?
|
| Europe | 23 | 2022 | 3423 | 0.700 |
Why?
|
| Nurses | 15 | 2019 | 2505 | 0.700 |
Why?
|
| Intraocular Pressure | 10 | 2024 | 1304 | 0.680 |
Why?
|
| Adult | 188 | 2025 | 223038 | 0.680 |
Why?
|
| Molecular Epidemiology | 8 | 2019 | 471 | 0.680 |
Why?
|
| Prospective Studies | 89 | 2025 | 54806 | 0.670 |
Why?
|
| Colorectal Neoplasms | 26 | 2020 | 6942 | 0.670 |
Why?
|
| Chromosomes, Human, Pair 5 | 9 | 2017 | 386 | 0.660 |
Why?
|
| Adenocarcinoma | 16 | 2021 | 6364 | 0.660 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 4 | 2018 | 93 | 0.640 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 9 | 2016 | 416 | 0.640 |
Why?
|
| Principal Component Analysis | 9 | 2015 | 951 | 0.620 |
Why?
|
| Metabolomics | 8 | 2023 | 1668 | 0.620 |
Why?
|
| Inheritance Patterns | 7 | 2019 | 345 | 0.620 |
Why?
|
| Multivariate Analysis | 20 | 2021 | 12057 | 0.620 |
Why?
|
| Skin Neoplasms | 22 | 2020 | 5849 | 0.610 |
Why?
|
| Metabolome | 5 | 2023 | 1005 | 0.610 |
Why?
|
| Telomerase | 9 | 2018 | 749 | 0.610 |
Why?
|
| Disease | 7 | 2017 | 676 | 0.600 |
Why?
|
| BRCA2 Protein | 7 | 2023 | 800 | 0.600 |
Why?
|
| Chromosomes, Human, Pair 8 | 8 | 2018 | 451 | 0.580 |
Why?
|
| Cohort Studies | 84 | 2022 | 41647 | 0.580 |
Why?
|
| Meta-Analysis as Topic | 15 | 2017 | 1370 | 0.570 |
Why?
|
| Genetics, Population | 8 | 2021 | 943 | 0.560 |
Why?
|
| Postmenopause | 15 | 2024 | 2515 | 0.560 |
Why?
|
| Carotenoids | 5 | 2021 | 619 | 0.560 |
Why?
|
| Polymorphism, Genetic | 20 | 2017 | 4247 | 0.550 |
Why?
|
| Computational Biology | 12 | 2021 | 3559 | 0.550 |
Why?
|
| Carcinoma, Squamous Cell | 12 | 2020 | 4044 | 0.540 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2018 | 223 | 0.540 |
Why?
|
| Genetic Diseases, Inborn | 5 | 2016 | 605 | 0.540 |
Why?
|
| Vital Capacity | 2 | 2017 | 995 | 0.540 |
Why?
|
| Neoplasms | 27 | 2025 | 22340 | 0.520 |
Why?
|
| Penetrance | 6 | 2023 | 388 | 0.520 |
Why?
|
| Receptors, Progesterone | 11 | 2022 | 1153 | 0.520 |
Why?
|
| Life Style | 7 | 2025 | 3926 | 0.500 |
Why?
|
| Lipid Metabolism | 4 | 2020 | 1892 | 0.500 |
Why?
|
| Genetic Linkage | 9 | 2013 | 2341 | 0.490 |
Why?
|
| Heredity | 2 | 2013 | 149 | 0.490 |
Why?
|
| Gonadal Steroid Hormones | 11 | 2017 | 705 | 0.480 |
Why?
|
| Forced Expiratory Volume | 3 | 2017 | 1828 | 0.480 |
Why?
|
| Menopause | 14 | 2023 | 1659 | 0.480 |
Why?
|
| Factor XII | 1 | 2014 | 20 | 0.480 |
Why?
|
| Bees | 2 | 2014 | 48 | 0.470 |
Why?
|
| Thrombosis | 6 | 2023 | 2949 | 0.470 |
Why?
|
| Genetic Pleiotropy | 6 | 2022 | 182 | 0.470 |
Why?
|
| Tobacco Use Disorder | 7 | 2019 | 708 | 0.470 |
Why?
|
| Carcinoma, Basal Cell | 8 | 2019 | 566 | 0.470 |
Why?
|
| Infarction, Middle Cerebral Artery | 4 | 2023 | 485 | 0.460 |
Why?
|
| Factor XI | 1 | 2014 | 40 | 0.460 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2012 | 586 | 0.460 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 786 | 0.450 |
Why?
|
| Fatty Acids | 3 | 2018 | 1806 | 0.440 |
Why?
|
| Metabolic Networks and Pathways | 8 | 2018 | 798 | 0.440 |
Why?
|
| Likelihood Functions | 12 | 2023 | 993 | 0.430 |
Why?
|
| Alcohol Drinking | 11 | 2024 | 4040 | 0.430 |
Why?
|
| Receptors, Somatostatin | 2 | 2014 | 138 | 0.430 |
Why?
|
| Molecular Sequence Annotation | 7 | 2021 | 523 | 0.420 |
Why?
|
| Gene Expression | 13 | 2023 | 7584 | 0.420 |
Why?
|
| Adiposity | 7 | 2023 | 1890 | 0.420 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2019 | 3655 | 0.420 |
Why?
|
| Toll-Like Receptor 6 | 2 | 2010 | 29 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 2 | 7 | 2021 | 313 | 0.420 |
Why?
|
| Polycystic Ovary Syndrome | 4 | 2022 | 389 | 0.420 |
Why?
|
| Genetics, Medical | 3 | 2021 | 334 | 0.420 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 3 | 2010 | 58 | 0.410 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 3 | 2010 | 207 | 0.410 |
Why?
|
| Mammography | 12 | 2022 | 2423 | 0.400 |
Why?
|
| Logistic Models | 37 | 2021 | 13266 | 0.400 |
Why?
|
| Ischemic Attack, Transient | 2 | 2014 | 870 | 0.400 |
Why?
|
| Receptors, Nicotinic | 6 | 2015 | 494 | 0.390 |
Why?
|
| Carcinoma, Lobular | 4 | 2021 | 471 | 0.390 |
Why?
|
| Diabetes Complications | 3 | 2020 | 1316 | 0.390 |
Why?
|
| Premenopause | 8 | 2021 | 1037 | 0.390 |
Why?
|
| Bayes Theorem | 12 | 2023 | 2354 | 0.390 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2016 | 3796 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 1 | 5 | 2016 | 640 | 0.380 |
Why?
|
| United States | 66 | 2024 | 72898 | 0.380 |
Why?
|
| Aged, 80 and over | 52 | 2022 | 59488 | 0.370 |
Why?
|
| Sample Size | 11 | 2022 | 845 | 0.370 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2021 | 8611 | 0.360 |
Why?
|
| Reproduction | 5 | 2023 | 641 | 0.360 |
Why?
|
| Signal Transduction | 23 | 2021 | 23600 | 0.360 |
Why?
|
| Databases, Genetic | 9 | 2020 | 1751 | 0.360 |
Why?
|
| Research Design | 9 | 2022 | 6208 | 0.350 |
Why?
|
| Waist-Hip Ratio | 5 | 2016 | 520 | 0.350 |
Why?
|
| Proportional Hazards Models | 25 | 2025 | 12509 | 0.350 |
Why?
|
| Neoplasm Proteins | 9 | 2019 | 3596 | 0.350 |
Why?
|
| Epigenomics | 1 | 2016 | 959 | 0.350 |
Why?
|
| DNA-Binding Proteins | 15 | 2023 | 9601 | 0.350 |
Why?
|
| Birth Order | 2 | 2016 | 93 | 0.350 |
Why?
|
| Estrogen Replacement Therapy | 7 | 2024 | 1206 | 0.340 |
Why?
|
| von Willebrand Factor | 1 | 2014 | 676 | 0.340 |
Why?
|
| National Cancer Institute (U.S.) | 6 | 2015 | 299 | 0.340 |
Why?
|
| Carcinoma, Ductal, Breast | 5 | 2025 | 1083 | 0.340 |
Why?
|
| Chromosomes, Human | 5 | 2017 | 437 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2018 | 430 | 0.330 |
Why?
|
| Follow-Up Studies | 40 | 2024 | 39194 | 0.330 |
Why?
|
| Obesity | 22 | 2023 | 13075 | 0.330 |
Why?
|
| Age of Onset | 8 | 2025 | 3343 | 0.330 |
Why?
|
| Mutation | 18 | 2023 | 30196 | 0.330 |
Why?
|
| Receptors, Leptin | 4 | 2023 | 355 | 0.330 |
Why?
|
| Exercise | 5 | 2019 | 5937 | 0.330 |
Why?
|
| Republic of Korea | 2 | 2023 | 588 | 0.330 |
Why?
|
| Statistics as Topic | 3 | 2010 | 2352 | 0.330 |
Why?
|
| Genetic Research | 3 | 2011 | 173 | 0.320 |
Why?
|
| Lung Neoplasms | 20 | 2019 | 13451 | 0.320 |
Why?
|
| Leptin | 4 | 2023 | 1596 | 0.320 |
Why?
|
| Arylamine N-Acetyltransferase | 2 | 2023 | 87 | 0.320 |
Why?
|
| Carcinoma | 5 | 2012 | 2312 | 0.320 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 5 | 2019 | 220 | 0.320 |
Why?
|
| Siblings | 5 | 2013 | 828 | 0.310 |
Why?
|
| Linear Models | 13 | 2021 | 5876 | 0.310 |
Why?
|
| Environmental Exposure | 6 | 2020 | 4543 | 0.310 |
Why?
|
| Leukocytes | 6 | 2019 | 2027 | 0.310 |
Why?
|
| Light | 2 | 2014 | 1364 | 0.310 |
Why?
|
| Esophageal Neoplasms | 3 | 2014 | 1661 | 0.310 |
Why?
|
| Lymphoma, Non-Hodgkin | 3 | 2022 | 1376 | 0.310 |
Why?
|
| Mammary Glands, Human | 3 | 2015 | 199 | 0.300 |
Why?
|
| DNA Methylation | 5 | 2020 | 4424 | 0.300 |
Why?
|
| Urinary Bladder Neoplasms | 6 | 2023 | 2176 | 0.300 |
Why?
|
| Anti-Mullerian Hormone | 2 | 2022 | 420 | 0.290 |
Why?
|
| Puberty | 2 | 2024 | 491 | 0.290 |
Why?
|
| Regression Analysis | 10 | 2018 | 6321 | 0.280 |
Why?
|
| Family | 5 | 2018 | 3209 | 0.280 |
Why?
|
| Nerve Tissue Proteins | 10 | 2019 | 4392 | 0.280 |
Why?
|
| Cerebrovascular Disorders | 1 | 2014 | 1470 | 0.280 |
Why?
|
| Disease Susceptibility | 11 | 2020 | 1789 | 0.280 |
Why?
|
| Low Tension Glaucoma | 2 | 2024 | 24 | 0.270 |
Why?
|
| Cues | 2 | 2014 | 877 | 0.270 |
Why?
|
| Estrone | 5 | 2021 | 234 | 0.270 |
Why?
|
| Hormones | 3 | 2018 | 863 | 0.270 |
Why?
|
| Melanoma | 9 | 2020 | 5719 | 0.270 |
Why?
|
| Sequence Deletion | 3 | 2021 | 1495 | 0.260 |
Why?
|
| Gallstones | 2 | 2021 | 285 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2011 | 360 | 0.260 |
Why?
|
| Prolactin | 3 | 2024 | 625 | 0.260 |
Why?
|
| Aromatase | 4 | 2012 | 147 | 0.260 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 11888 | 0.260 |
Why?
|
| Heterozygote | 9 | 2023 | 2794 | 0.260 |
Why?
|
| Cardiovascular Diseases | 9 | 2023 | 15651 | 0.250 |
Why?
|
| Blood Platelets | 5 | 2023 | 2464 | 0.250 |
Why?
|
| Toll-Like Receptors | 1 | 2009 | 583 | 0.250 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 2020 | 792 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2020 | 323 | 0.250 |
Why?
|
| Endometriosis | 3 | 2023 | 870 | 0.250 |
Why?
|
| Area Under Curve | 4 | 2015 | 1638 | 0.250 |
Why?
|
| Probability | 5 | 2021 | 2475 | 0.240 |
Why?
|
| Vitamin A | 3 | 2013 | 610 | 0.240 |
Why?
|
| Prognosis | 32 | 2021 | 29921 | 0.240 |
Why?
|
| Gene Expression Profiling | 11 | 2020 | 9524 | 0.240 |
Why?
|
| Epidemiologic Research Design | 1 | 2008 | 368 | 0.240 |
Why?
|
| Estrogen Receptor beta | 4 | 2011 | 171 | 0.240 |
Why?
|
| Receptor, Melanocortin, Type 1 | 3 | 2018 | 76 | 0.240 |
Why?
|
| Triglycerides | 4 | 2020 | 2441 | 0.230 |
Why?
|
| Early Detection of Cancer | 5 | 2022 | 3236 | 0.230 |
Why?
|
| Diet | 15 | 2022 | 8086 | 0.230 |
Why?
|
| ROC Curve | 7 | 2023 | 3620 | 0.230 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2024 | 163 | 0.230 |
Why?
|
| Sensitivity and Specificity | 6 | 2014 | 14652 | 0.230 |
Why?
|
| Rh Isoimmunization | 1 | 2004 | 23 | 0.230 |
Why?
|
| Sex Hormone-Binding Globulin | 5 | 2014 | 558 | 0.230 |
Why?
|
| Age Factors | 19 | 2019 | 18380 | 0.220 |
Why?
|
| Skin Pigmentation | 3 | 2013 | 279 | 0.220 |
Why?
|
| Incidence | 17 | 2023 | 21480 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 7 | 2021 | 4772 | 0.220 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 3 | 2010 | 125 | 0.220 |
Why?
|
| Breast | 6 | 2022 | 1946 | 0.220 |
Why?
|
| DNA Repair | 5 | 2015 | 2048 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 2019 | 412 | 0.220 |
Why?
|
| Australia | 5 | 2014 | 1258 | 0.220 |
Why?
|
| Membrane Proteins | 11 | 2023 | 7851 | 0.220 |
Why?
|
| Alopecia | 2 | 2018 | 414 | 0.220 |
Why?
|
| Receptors, Androgen | 5 | 2014 | 1088 | 0.210 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2009 | 532 | 0.210 |
Why?
|
| Artifacts | 2 | 2011 | 1893 | 0.210 |
Why?
|
| Homozygote | 5 | 2015 | 1775 | 0.210 |
Why?
|
| False Positive Reactions | 5 | 2021 | 955 | 0.210 |
Why?
|
| Pedigree | 5 | 2019 | 4526 | 0.210 |
Why?
|
| Algorithms | 16 | 2023 | 14071 | 0.210 |
Why?
|
| Blood Pressure Determination | 2 | 2003 | 647 | 0.210 |
Why?
|
| Nevus, Pigmented | 2 | 2018 | 227 | 0.210 |
Why?
|
| Diabetic Angiopathies | 2 | 2018 | 805 | 0.210 |
Why?
|
| Progesterone | 3 | 2021 | 752 | 0.210 |
Why?
|
| DNA Copy Number Variations | 3 | 2022 | 2045 | 0.210 |
Why?
|
| Fertility | 3 | 2023 | 768 | 0.210 |
Why?
|
| Vitamin D Deficiency | 4 | 2020 | 1348 | 0.200 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2017 | 729 | 0.200 |
Why?
|
| Estrogens | 6 | 2022 | 1529 | 0.200 |
Why?
|
| Glycoproteins | 1 | 2010 | 2195 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 7 | 3 | 2019 | 311 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2016 | 191 | 0.200 |
Why?
|
| Feeding Behavior | 6 | 2020 | 3211 | 0.200 |
Why?
|
| Fenofibrate | 2 | 2020 | 87 | 0.200 |
Why?
|
| Lymphoma, B-Cell | 3 | 2020 | 943 | 0.200 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2025 | 920 | 0.200 |
Why?
|
| Homocysteine | 4 | 2015 | 638 | 0.200 |
Why?
|
| Parity | 3 | 2016 | 931 | 0.200 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2012 | 3733 | 0.200 |
Why?
|
| Multigene Family | 4 | 2017 | 1080 | 0.200 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 3 | 2013 | 173 | 0.190 |
Why?
|
| Software | 9 | 2017 | 4462 | 0.190 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2016 | 488 | 0.190 |
Why?
|
| Hormone Replacement Therapy | 3 | 2022 | 753 | 0.190 |
Why?
|
| Epidemiologic Studies | 3 | 2016 | 677 | 0.190 |
Why?
|
| Validation Studies as Topic | 2 | 2020 | 162 | 0.190 |
Why?
|
| Adiponectin | 4 | 2023 | 1119 | 0.190 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2021 | 28 | 0.190 |
Why?
|
| Biometry | 1 | 2004 | 571 | 0.190 |
Why?
|
| Depression | 7 | 2023 | 8230 | 0.190 |
Why?
|
| Ovary | 3 | 2021 | 956 | 0.190 |
Why?
|
| Pregnanediol | 1 | 2021 | 18 | 0.190 |
Why?
|
| Smoking Cessation | 4 | 2015 | 2084 | 0.180 |
Why?
|
| Medical History Taking | 3 | 2021 | 777 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 10 | 2021 | 5786 | 0.180 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 | 2017 | 1646 | 0.180 |
Why?
|
| Colonic Neoplasms | 4 | 2020 | 2531 | 0.180 |
Why?
|
| Sex Factors | 11 | 2020 | 10602 | 0.180 |
Why?
|
| Dietary Fats | 5 | 2019 | 2002 | 0.180 |
Why?
|
| Cation Transport Proteins | 1 | 2023 | 325 | 0.180 |
Why?
|
| Weight Loss | 2 | 2024 | 2710 | 0.180 |
Why?
|
| Cholesterol, HDL | 4 | 2022 | 1811 | 0.180 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2021 | 117 | 0.180 |
Why?
|
| Models, Theoretical | 5 | 2021 | 3564 | 0.180 |
Why?
|
| Random Allocation | 3 | 2018 | 2395 | 0.180 |
Why?
|
| Family Health | 3 | 2021 | 1253 | 0.170 |
Why?
|
| Receptor, Melanocortin, Type 4 | 3 | 2015 | 132 | 0.170 |
Why?
|
| Carcinogens, Environmental | 1 | 2020 | 70 | 0.170 |
Why?
|
| Lysophosphatidylcholines | 1 | 2020 | 77 | 0.170 |
Why?
|
| Aging | 7 | 2023 | 8731 | 0.170 |
Why?
|
| Fibrinolytic Agents | 3 | 2016 | 2080 | 0.170 |
Why?
|
| Mosaicism | 2 | 2015 | 481 | 0.170 |
Why?
|
| Vesicular Transport Proteins | 3 | 2020 | 376 | 0.170 |
Why?
|
| Pseudouridine | 1 | 2020 | 19 | 0.170 |
Why?
|
| Hair Color | 3 | 2009 | 132 | 0.170 |
Why?
|
| Sphingomyelins | 1 | 2020 | 102 | 0.170 |
Why?
|
| Fanconi Anemia Complementation Group C Protein | 1 | 2019 | 21 | 0.170 |
Why?
|
| Proteins | 9 | 2018 | 5995 | 0.170 |
Why?
|
| Tricarboxylic Acids | 2 | 2018 | 26 | 0.170 |
Why?
|
| Major Histocompatibility Complex | 2 | 2015 | 879 | 0.170 |
Why?
|
| Body Weight | 5 | 2024 | 4622 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2011 | 285 | 0.170 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2011 | 276 | 0.160 |
Why?
|
| Membrane Glycoproteins | 4 | 2015 | 3690 | 0.160 |
Why?
|
| Helicobacter pylori | 1 | 2023 | 380 | 0.160 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2018 | 1365 | 0.160 |
Why?
|
| Coronary Disease | 3 | 2015 | 5912 | 0.160 |
Why?
|
| Selenium | 2 | 2014 | 419 | 0.160 |
Why?
|
| Helicobacter Infections | 1 | 2023 | 390 | 0.160 |
Why?
|
| Cerebral Hemorrhage | 3 | 2016 | 2648 | 0.160 |
Why?
|
| Taste Perception | 1 | 2019 | 38 | 0.160 |
Why?
|
| Cooperative Behavior | 6 | 2016 | 1509 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 19 | 3 | 2014 | 350 | 0.160 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2020 | 226 | 0.160 |
Why?
|
| Homeodomain Proteins | 3 | 2020 | 2428 | 0.160 |
Why?
|
| Radon | 1 | 2020 | 90 | 0.160 |
Why?
|
| Apolipoproteins E | 2 | 2019 | 1458 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2023 | 2899 | 0.160 |
Why?
|
| Sex Characteristics | 7 | 2022 | 2643 | 0.160 |
Why?
|
| Ceramides | 1 | 2020 | 201 | 0.160 |
Why?
|
| Internationality | 2 | 2022 | 1007 | 0.160 |
Why?
|
| Kidney Neoplasms | 5 | 2019 | 4274 | 0.160 |
Why?
|
| Carrier Proteins | 2 | 2018 | 4913 | 0.160 |
Why?
|
| Gene Regulatory Networks | 5 | 2020 | 1749 | 0.160 |
Why?
|
| Survival Analysis | 11 | 2021 | 10070 | 0.150 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2019 | 3181 | 0.150 |
Why?
|
| Phosphatidylcholines | 1 | 2020 | 403 | 0.150 |
Why?
|
| PPAR alpha | 1 | 2020 | 176 | 0.150 |
Why?
|
| Twin Studies as Topic | 1 | 2018 | 103 | 0.150 |
Why?
|
| Kallikreins | 2 | 2011 | 220 | 0.150 |
Why?
|
| Microarray Analysis | 2 | 2019 | 752 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 6 | 2016 | 6069 | 0.150 |
Why?
|
| Nevus | 1 | 2020 | 205 | 0.150 |
Why?
|
| Blood Pressure | 4 | 2017 | 8532 | 0.150 |
Why?
|
| Epistasis, Genetic | 2 | 2011 | 353 | 0.150 |
Why?
|
| Particulate Matter | 3 | 2020 | 2624 | 0.150 |
Why?
|
| Polyps | 1 | 2020 | 200 | 0.150 |
Why?
|
| Schizophrenia | 4 | 2019 | 6971 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2014 | 416 | 0.150 |
Why?
|
| Testosterone | 4 | 2018 | 2494 | 0.150 |
Why?
|
| Arylalkylamine N-Acetyltransferase | 1 | 2017 | 13 | 0.140 |
Why?
|
| Reproducibility of Results | 17 | 2021 | 20125 | 0.140 |
Why?
|
| Aryldialkylphosphatase | 1 | 2017 | 64 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2016 | 127 | 0.140 |
Why?
|
| Causality | 5 | 2023 | 1248 | 0.140 |
Why?
|
| Heart Failure, Diastolic | 1 | 2018 | 77 | 0.140 |
Why?
|
| Diabetes Mellitus | 5 | 2020 | 5891 | 0.140 |
Why?
|
| Vitamin B 12 | 3 | 2009 | 532 | 0.140 |
Why?
|
| alpha-Linolenic Acid | 2 | 2009 | 145 | 0.140 |
Why?
|
| Leiomyoma | 1 | 2022 | 643 | 0.140 |
Why?
|
| Ribonucleoproteins | 2 | 2017 | 359 | 0.140 |
Why?
|
| Genetic Heterogeneity | 5 | 2018 | 735 | 0.140 |
Why?
|
| Oncogenes | 1 | 2023 | 1235 | 0.140 |
Why?
|
| Asparagus Plant | 1 | 2016 | 4 | 0.140 |
Why?
|
| Jews | 1 | 2019 | 357 | 0.140 |
Why?
|
| Neoplasm Staging | 13 | 2021 | 11206 | 0.140 |
Why?
|
| Women's Health | 5 | 2016 | 2084 | 0.140 |
Why?
|
| Energy Intake | 4 | 2018 | 2140 | 0.140 |
Why?
|
| Mutation, Missense | 4 | 2023 | 2589 | 0.140 |
Why?
|
| Data Interpretation, Statistical | 5 | 2011 | 2686 | 0.140 |
Why?
|
| Activin Receptors, Type II | 1 | 2017 | 122 | 0.140 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2023 | 1066 | 0.140 |
Why?
|
| Menopause, Premature | 2 | 2021 | 124 | 0.140 |
Why?
|
| Fecal Incontinence | 1 | 2019 | 245 | 0.140 |
Why?
|
| Factor X | 1 | 2016 | 64 | 0.140 |
Why?
|
| Receptor, Melanocortin, Type 2 | 1 | 2016 | 9 | 0.140 |
Why?
|
| Keratin-13 | 1 | 2016 | 11 | 0.140 |
Why?
|
| Circadian Clocks | 2 | 2020 | 168 | 0.140 |
Why?
|
| Hypoglycemic Agents | 3 | 2023 | 3110 | 0.130 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2017 | 149 | 0.130 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 27 | 0.130 |
Why?
|
| Heart Failure, Systolic | 1 | 2018 | 135 | 0.130 |
Why?
|
| Longitudinal Studies | 9 | 2020 | 14749 | 0.130 |
Why?
|
| Biotinidase | 1 | 2016 | 17 | 0.130 |
Why?
|
| Gout | 2 | 2015 | 620 | 0.130 |
Why?
|
| Dimethylnitrosamine | 3 | 1981 | 17 | 0.130 |
Why?
|
| TRPM Cation Channels | 1 | 2017 | 139 | 0.130 |
Why?
|
| Zebrafish Proteins | 1 | 2003 | 1017 | 0.130 |
Why?
|
| Tumor Burden | 2 | 2020 | 1885 | 0.130 |
Why?
|
| Interleukin-6 | 4 | 2013 | 3222 | 0.130 |
Why?
|
| beta-Carotene 15,15'-Monooxygenase | 2 | 2013 | 12 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2016 | 4520 | 0.130 |
Why?
|
| Stroke | 2 | 2017 | 9747 | 0.130 |
Why?
|
| Young Adult | 25 | 2021 | 59886 | 0.130 |
Why?
|
| Keratin-6 | 1 | 2015 | 15 | 0.130 |
Why?
|
| Dairy Products | 1 | 2019 | 491 | 0.130 |
Why?
|
| Cholesterol, LDL | 3 | 2022 | 2393 | 0.130 |
Why?
|
| Prothrombin | 1 | 2016 | 193 | 0.130 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.130 |
Why?
|
| Exfoliation Syndrome | 1 | 2017 | 113 | 0.130 |
Why?
|
| Hemostasis | 2 | 2016 | 467 | 0.130 |
Why?
|
| Keratin-5 | 1 | 2015 | 43 | 0.130 |
Why?
|
| Chromosome Aberrations | 4 | 2015 | 1774 | 0.130 |
Why?
|
| HLA Antigens | 3 | 2019 | 1339 | 0.130 |
Why?
|
| Steroid Hydroxylases | 2 | 2013 | 93 | 0.130 |
Why?
|
| Bronchial Neoplasms | 1 | 2016 | 109 | 0.130 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2016 | 40 | 0.130 |
Why?
|
| Genome | 4 | 2012 | 1753 | 0.130 |
Why?
|
| Waist Circumference | 3 | 2015 | 933 | 0.130 |
Why?
|
| Aqueous Humor | 1 | 2016 | 152 | 0.130 |
Why?
|
| Adolescent | 31 | 2024 | 88832 | 0.130 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2016 | 111 | 0.130 |
Why?
|
| Serine Endopeptidases | 2 | 2023 | 1024 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2019 | 3247 | 0.130 |
Why?
|
| Epigenesis, Genetic | 4 | 2016 | 3819 | 0.130 |
Why?
|
| Macular Degeneration | 1 | 2023 | 1014 | 0.130 |
Why?
|
| Interferon Regulatory Factors | 3 | 2018 | 271 | 0.120 |
Why?
|
| Membrane Transport Proteins | 4 | 2015 | 1028 | 0.120 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2015 | 95 | 0.120 |
Why?
|
| OX40 Ligand | 1 | 2015 | 57 | 0.120 |
Why?
|
| Keratinocytes | 2 | 2017 | 863 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 1657 | 0.120 |
Why?
|
| Hypolipidemic Agents | 1 | 2020 | 608 | 0.120 |
Why?
|
| Health Personnel | 6 | 2024 | 3390 | 0.120 |
Why?
|
| Cytochrome P-450 CYP1A2 | 2 | 2014 | 68 | 0.120 |
Why?
|
| Urinary Incontinence | 1 | 2019 | 491 | 0.120 |
Why?
|
| Twins, Dizygotic | 1 | 2016 | 236 | 0.120 |
Why?
|
| Urine | 1 | 2016 | 360 | 0.120 |
Why?
|
| Point Mutation | 2 | 2017 | 1590 | 0.120 |
Why?
|
| Caveolin 1 | 2 | 2014 | 255 | 0.120 |
Why?
|
| Circadian Rhythm | 3 | 2017 | 2590 | 0.120 |
Why?
|
| Inflammation | 7 | 2021 | 10850 | 0.120 |
Why?
|
| Repressor Proteins | 4 | 2019 | 2968 | 0.120 |
Why?
|
| Microsatellite Instability | 2 | 2017 | 728 | 0.120 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2015 | 84 | 0.120 |
Why?
|
| Interleukin-15 | 1 | 2015 | 186 | 0.120 |
Why?
|
| Dyssomnias | 1 | 2014 | 28 | 0.120 |
Why?
|
| Coffea | 1 | 2014 | 22 | 0.120 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2017 | 373 | 0.120 |
Why?
|
| Cognition | 3 | 2019 | 7048 | 0.120 |
Why?
|
| Meat | 2 | 2014 | 588 | 0.120 |
Why?
|
| Blood Specimen Collection | 1 | 2016 | 238 | 0.120 |
Why?
|
| Behavior, Animal | 2 | 2014 | 1865 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 3 | 2014 | 578 | 0.110 |
Why?
|
| Acetyl Coenzyme A | 1 | 2014 | 74 | 0.110 |
Why?
|
| Parents | 5 | 2020 | 3592 | 0.110 |
Why?
|
| Olfaction Disorders | 1 | 2016 | 223 | 0.110 |
Why?
|
| beta Catenin | 2 | 2013 | 1043 | 0.110 |
Why?
|
| Adenoma | 2 | 2020 | 2152 | 0.110 |
Why?
|
| Cyclin E | 1 | 2014 | 156 | 0.110 |
Why?
|
| High Mobility Group Proteins | 2 | 2012 | 180 | 0.110 |
Why?
|
| Agouti Signaling Protein | 2 | 2011 | 22 | 0.110 |
Why?
|
| Aspirin | 2 | 2017 | 3134 | 0.110 |
Why?
|
| Coronary Artery Disease | 5 | 2018 | 6546 | 0.110 |
Why?
|
| Organ Size | 1 | 2019 | 2261 | 0.110 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2016 | 253 | 0.110 |
Why?
|
| Caveolin 2 | 1 | 2013 | 25 | 0.110 |
Why?
|
| Twins, Monozygotic | 1 | 2016 | 469 | 0.110 |
Why?
|
| Apolipoprotein E2 | 1 | 2014 | 133 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2013 | 378 | 0.110 |
Why?
|
| Testicular Neoplasms | 2 | 2017 | 786 | 0.110 |
Why?
|
| Ocular Physiological Phenomena | 1 | 2014 | 67 | 0.110 |
Why?
|
| Beverages | 1 | 2019 | 819 | 0.110 |
Why?
|
| Spirometry | 1 | 2017 | 929 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2020 | 2243 | 0.110 |
Why?
|
| Intestinal Neoplasms | 1 | 2016 | 313 | 0.110 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2018 | 1441 | 0.110 |
Why?
|
| Receptor, Insulin | 1 | 2017 | 837 | 0.110 |
Why?
|
| Lipids | 6 | 2022 | 3316 | 0.110 |
Why?
|
| Casein Kinase II | 1 | 2014 | 120 | 0.110 |
Why?
|
| Publishing | 2 | 2011 | 835 | 0.110 |
Why?
|
| Domperidone | 1 | 2013 | 24 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 1140 | 0.110 |
Why?
|
| Genealogy and Heraldry | 1 | 2013 | 29 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 619 | 0.110 |
Why?
|
| Osteoarthritis | 1 | 2021 | 1051 | 0.110 |
Why?
|
| Dermatitis, Atopic | 1 | 2021 | 729 | 0.110 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 180 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2016 | 1365 | 0.110 |
Why?
|
| Open Reading Frames | 1 | 2016 | 820 | 0.110 |
Why?
|
| Chronic Disease | 5 | 2018 | 9347 | 0.110 |
Why?
|
| Air Pollutants | 4 | 2020 | 2923 | 0.110 |
Why?
|
| Genomic Structural Variation | 1 | 2013 | 81 | 0.110 |
Why?
|
| Phospholipase D | 1 | 2013 | 71 | 0.100 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 770 | 0.100 |
Why?
|
| Prostate-Specific Antigen | 3 | 2012 | 2464 | 0.100 |
Why?
|
| Calcium Signaling | 1 | 2017 | 733 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2015 | 3807 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3251 | 0.100 |
Why?
|
| Iron | 1 | 2021 | 1816 | 0.100 |
Why?
|
| Lod Score | 2 | 2003 | 598 | 0.100 |
Why?
|
| Estradiol | 4 | 2014 | 1947 | 0.100 |
Why?
|
| Myositis | 1 | 2015 | 270 | 0.100 |
Why?
|
| Selenoproteins | 2 | 2014 | 216 | 0.100 |
Why?
|
| Trichomonas Infections | 1 | 2012 | 41 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2016 | 4058 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2012 | 69 | 0.100 |
Why?
|
| Bone Neoplasms | 3 | 2015 | 2567 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2020 | 869 | 0.100 |
Why?
|
| Hodgkin Disease | 2 | 2011 | 1383 | 0.100 |
Why?
|
| Blood Glucose | 5 | 2022 | 6425 | 0.100 |
Why?
|
| Antibody Formation | 1 | 2017 | 1391 | 0.100 |
Why?
|
| Perception | 2 | 2015 | 1205 | 0.100 |
Why?
|
| Carbon | 2 | 2013 | 677 | 0.100 |
Why?
|
| Homeostasis | 1 | 2023 | 3336 | 0.100 |
Why?
|
| Hyperuricemia | 1 | 2015 | 221 | 0.100 |
Why?
|
| Myocardial Infarction | 5 | 2016 | 11501 | 0.100 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 250 | 0.100 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2014 | 266 | 0.100 |
Why?
|
| Diuretics | 1 | 2015 | 613 | 0.090 |
Why?
|
| Confidence Intervals | 5 | 2012 | 2910 | 0.090 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2023 | 1608 | 0.090 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 222 | 0.090 |
Why?
|
| Child | 20 | 2024 | 80563 | 0.090 |
Why?
|
| Adipose Tissue | 6 | 2016 | 3312 | 0.090 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2011 | 99 | 0.090 |
Why?
|
| Genetic Phenomena | 1 | 2011 | 6 | 0.090 |
Why?
|
| Nuclear Proteins | 5 | 2022 | 5783 | 0.090 |
Why?
|
| Methionine | 2 | 2011 | 569 | 0.090 |
Why?
|
| Norway | 3 | 2016 | 499 | 0.090 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2016 | 550 | 0.090 |
Why?
|
| Models, Biological | 5 | 2019 | 9443 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3946 | 0.090 |
Why?
|
| Estradiol Dehydrogenases | 1 | 2010 | 16 | 0.090 |
Why?
|
| Costa Rica | 5 | 2009 | 186 | 0.090 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2012 | 320 | 0.090 |
Why?
|
| Primary Ovarian Insufficiency | 3 | 2021 | 104 | 0.090 |
Why?
|
| Cyclin D1 | 1 | 2013 | 449 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2014 | 6203 | 0.090 |
Why?
|
| Pulmonary Embolism | 2 | 2018 | 2598 | 0.090 |
Why?
|
| Glycine | 1 | 2014 | 672 | 0.090 |
Why?
|
| CpG Islands | 3 | 2020 | 1207 | 0.090 |
Why?
|
| Physical Chromosome Mapping | 1 | 2011 | 183 | 0.090 |
Why?
|
| Behavior, Addictive | 1 | 2016 | 423 | 0.090 |
Why?
|
| Ferritins | 1 | 2014 | 600 | 0.090 |
Why?
|
| Osteosarcoma | 2 | 2015 | 909 | 0.090 |
Why?
|
| Data Collection | 2 | 2018 | 3318 | 0.090 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 268 | 0.090 |
Why?
|
| Hydro-Lyases | 1 | 2010 | 93 | 0.090 |
Why?
|
| Calcium | 3 | 2023 | 5767 | 0.090 |
Why?
|
| Laminin | 1 | 2012 | 404 | 0.090 |
Why?
|
| Transcription Factors | 4 | 2017 | 12131 | 0.090 |
Why?
|
| Drinking Behavior | 1 | 2011 | 101 | 0.090 |
Why?
|
| Amide Synthases | 1 | 2010 | 14 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 710 | 0.090 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2010 | 57 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2014 | 8733 | 0.090 |
Why?
|
| Antiporters | 2 | 2009 | 275 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2268 | 0.090 |
Why?
|
| Motivation | 2 | 2013 | 2018 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2015 | 993 | 0.090 |
Why?
|
| Lymphoma, Follicular | 1 | 2014 | 459 | 0.090 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 2226 | 0.090 |
Why?
|
| RNA | 2 | 2018 | 2717 | 0.090 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2017 | 538 | 0.080 |
Why?
|
| Periodontitis | 1 | 2015 | 576 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2010 | 2878 | 0.080 |
Why?
|
| China | 2 | 2013 | 2385 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 4 | 2021 | 3602 | 0.080 |
Why?
|
| Platelet Membrane Glycoproteins | 2 | 2023 | 282 | 0.080 |
Why?
|
| Antigens, CD | 2 | 2017 | 4025 | 0.080 |
Why?
|
| Neuroendocrine Tumors | 1 | 2016 | 654 | 0.080 |
Why?
|
| Carcinoma in Situ | 1 | 2015 | 779 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2016 | 2796 | 0.080 |
Why?
|
| Prostatic Secretory Proteins | 1 | 2009 | 24 | 0.080 |
Why?
|
| Dietary Carbohydrates | 2 | 2017 | 894 | 0.080 |
Why?
|
| NF-kappa B | 2 | 2009 | 2485 | 0.080 |
Why?
|
| Predictive Value of Tests | 6 | 2020 | 15398 | 0.080 |
Why?
|
| Folic Acid | 3 | 2011 | 1339 | 0.080 |
Why?
|
| Prescription Drugs | 1 | 2016 | 634 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2018 | 1546 | 0.080 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2010 | 129 | 0.080 |
Why?
|
| Vitamin B Complex | 1 | 2011 | 299 | 0.080 |
Why?
|
| Animals | 24 | 2024 | 168759 | 0.080 |
Why?
|
| Nuclear Family | 2 | 2000 | 311 | 0.080 |
Why?
|
| Air Pollution | 2 | 2020 | 2380 | 0.080 |
Why?
|
| Registries | 5 | 2020 | 8297 | 0.080 |
Why?
|
| Actins | 1 | 2016 | 2056 | 0.080 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 686 | 0.080 |
Why?
|
| Quality Control | 4 | 2014 | 837 | 0.080 |
Why?
|
| Genome, Mitochondrial | 1 | 2009 | 68 | 0.080 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2008 | 23 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 1801 | 0.080 |
Why?
|
| Population Surveillance | 5 | 2019 | 2590 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2018 | 2880 | 0.080 |
Why?
|
| TCF Transcription Factors | 1 | 2009 | 137 | 0.080 |
Why?
|
| Mass Screening | 2 | 2022 | 5445 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1624 | 0.080 |
Why?
|
| Sunbathing | 1 | 2009 | 66 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2009 | 274 | 0.080 |
Why?
|
| Multiple Sclerosis | 2 | 2015 | 3213 | 0.080 |
Why?
|
| Disclosure | 2 | 2011 | 756 | 0.080 |
Why?
|
| Bipolar Disorder | 2 | 2023 | 5128 | 0.080 |
Why?
|
| Work Schedule Tolerance | 1 | 2012 | 554 | 0.070 |
Why?
|
| DNA | 3 | 2019 | 7202 | 0.070 |
Why?
|
| Interleukin-18 | 1 | 2010 | 251 | 0.070 |
Why?
|
| Marriage | 1 | 2010 | 351 | 0.070 |
Why?
|
| Fucosyltransferases | 1 | 2008 | 118 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2021 | 6499 | 0.070 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2008 | 51 | 0.070 |
Why?
|
| Puberty, Delayed | 2 | 2024 | 124 | 0.070 |
Why?
|
| Toll-Like Receptor 10 | 1 | 2007 | 12 | 0.070 |
Why?
|
| Fats | 1 | 2008 | 99 | 0.070 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 1140 | 0.070 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1434 | 0.070 |
Why?
|
| Epidemiologic Methods | 2 | 2010 | 1326 | 0.070 |
Why?
|
| Time Factors | 11 | 2021 | 40065 | 0.070 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2007 | 48 | 0.070 |
Why?
|
| E-Selectin | 1 | 2010 | 576 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2017 | 2115 | 0.070 |
Why?
|
| One-Carbon Group Transferases | 1 | 2007 | 6 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 1499 | 0.070 |
Why?
|
| Puberty, Precocious | 2 | 2024 | 163 | 0.070 |
Why?
|
| Anemia, Sickle Cell | 1 | 2016 | 1067 | 0.070 |
Why?
|
| Insulin Resistance | 4 | 2017 | 3985 | 0.070 |
Why?
|
| Receptors, Interleukin | 1 | 2008 | 243 | 0.070 |
Why?
|
| Heart Rate | 2 | 2023 | 4203 | 0.070 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2015 | 857 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 594 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2018 | 2892 | 0.070 |
Why?
|
| Japan | 1 | 2011 | 1415 | 0.070 |
Why?
|
| Antioxidants | 1 | 2015 | 1670 | 0.070 |
Why?
|
| Checklist | 2 | 2011 | 848 | 0.070 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2008 | 226 | 0.070 |
Why?
|
| Insulin | 4 | 2022 | 6599 | 0.070 |
Why?
|
| Carnitine | 2 | 2018 | 253 | 0.070 |
Why?
|
| Microfilament Proteins | 3 | 2019 | 1130 | 0.070 |
Why?
|
| Vitamin E | 1 | 2011 | 869 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 2013 | 874 | 0.070 |
Why?
|
| Visual Fields | 1 | 2013 | 1063 | 0.070 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2007 | 85 | 0.070 |
Why?
|
| Uric Acid | 1 | 2012 | 809 | 0.070 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2006 | 13 | 0.070 |
Why?
|
| Caffeine | 1 | 2011 | 702 | 0.070 |
Why?
|
| Glycemic Index | 1 | 2009 | 400 | 0.070 |
Why?
|
| Cluster Analysis | 3 | 2021 | 2720 | 0.070 |
Why?
|
| Receptors, Calcitriol | 1 | 2009 | 361 | 0.070 |
Why?
|
| I-kappa B Proteins | 1 | 2007 | 209 | 0.070 |
Why?
|
| MicroRNAs | 3 | 2018 | 3785 | 0.070 |
Why?
|
| Vision Disorders | 1 | 2013 | 1087 | 0.060 |
Why?
|
| Lung | 3 | 2019 | 10033 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2023 | 10383 | 0.060 |
Why?
|
| Eating | 2 | 2013 | 1539 | 0.060 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 898 | 0.060 |
Why?
|
| Trinucleotide Repeats | 3 | 2014 | 258 | 0.060 |
Why?
|
| Biosynthetic Pathways | 1 | 2006 | 138 | 0.060 |
Why?
|
| Warfarin | 1 | 2014 | 1494 | 0.060 |
Why?
|
| Transcription Factor RelA | 1 | 2007 | 252 | 0.060 |
Why?
|
| Immunity | 1 | 2012 | 1002 | 0.060 |
Why?
|
| C-Reactive Protein | 3 | 2018 | 3850 | 0.060 |
Why?
|
| Adipokines | 2 | 2023 | 308 | 0.060 |
Why?
|
| Genes, Dominant | 2 | 2016 | 856 | 0.060 |
Why?
|
| Rad51 Recombinase | 2 | 2018 | 191 | 0.060 |
Why?
|
| Introns | 3 | 2017 | 966 | 0.060 |
Why?
|
| Steroids | 1 | 2010 | 933 | 0.060 |
Why?
|
| Receptor, erbB-2 | 3 | 2022 | 2593 | 0.060 |
Why?
|
| Hypertension | 3 | 2019 | 8626 | 0.060 |
Why?
|
| Selection, Genetic | 2 | 2023 | 878 | 0.060 |
Why?
|
| Platelet Activation | 2 | 2023 | 645 | 0.060 |
Why?
|
| Sperm Count | 1 | 2006 | 227 | 0.060 |
Why?
|
| Indoles | 1 | 2013 | 1839 | 0.060 |
Why?
|
| Epidemiology | 1 | 2007 | 279 | 0.060 |
Why?
|
| Wnt Proteins | 2 | 2013 | 722 | 0.060 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2024 | 45 | 0.060 |
Why?
|
| Choice Behavior | 1 | 2011 | 844 | 0.060 |
Why?
|
| Cotinine | 2 | 2017 | 206 | 0.060 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 2736 | 0.060 |
Why?
|
| Poisson Distribution | 1 | 2006 | 508 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2007 | 483 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2013 | 1393 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 5189 | 0.060 |
Why?
|
| Glaucoma | 1 | 2014 | 1194 | 0.060 |
Why?
|
| Ozone | 2 | 2006 | 499 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 2921 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2014 | 1327 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2017 | 3000 | 0.060 |
Why?
|
| Mice | 12 | 2024 | 81818 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2024 | 1241 | 0.060 |
Why?
|
| Pharmacogenetics | 2 | 2020 | 682 | 0.060 |
Why?
|
| Acute Disease | 1 | 2014 | 7232 | 0.060 |
Why?
|
| Celiac Disease | 1 | 2012 | 820 | 0.060 |
Why?
|
| Body Size | 3 | 2011 | 459 | 0.060 |
Why?
|
| Genomic Imprinting | 2 | 2017 | 326 | 0.060 |
Why?
|
| Cholesterol | 2 | 2016 | 2898 | 0.060 |
Why?
|
| Genes, Neoplasm | 1 | 2005 | 370 | 0.060 |
Why?
|
| Iceland | 2 | 2014 | 183 | 0.050 |
Why?
|
| Self Report | 4 | 2018 | 3771 | 0.050 |
Why?
|
| Interleukins | 1 | 2008 | 791 | 0.050 |
Why?
|
| Hematologic Neoplasms | 1 | 2015 | 1927 | 0.050 |
Why?
|
| Cell Line, Tumor | 6 | 2017 | 17075 | 0.050 |
Why?
|
| Receptors, Adiponectin | 1 | 2023 | 82 | 0.050 |
Why?
|
| Glutathione Peroxidase | 1 | 2004 | 256 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 2247 | 0.050 |
Why?
|
| Receptors, CCR5 | 1 | 2005 | 491 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 1915 | 0.050 |
Why?
|
| Anxiety | 1 | 2018 | 4668 | 0.050 |
Why?
|
| Survival Rate | 5 | 2017 | 12795 | 0.050 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2024 | 187 | 0.050 |
Why?
|
| Cations | 1 | 2023 | 240 | 0.050 |
Why?
|
| Health Surveys | 3 | 2020 | 4056 | 0.050 |
Why?
|
| Matched-Pair Analysis | 2 | 2000 | 284 | 0.050 |
Why?
|
| Binding Sites | 3 | 2017 | 6001 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 3715 | 0.050 |
Why?
|
| Pregnancy | 5 | 2020 | 30258 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2015 | 2283 | 0.050 |
Why?
|
| Eczema | 1 | 2005 | 246 | 0.050 |
Why?
|
| Longevity | 2 | 2021 | 1087 | 0.050 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2003 | 182 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 651 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 22331 | 0.050 |
Why?
|
| Linoleic Acid | 2 | 2017 | 157 | 0.050 |
Why?
|
| Disease Progression | 6 | 2016 | 13631 | 0.050 |
Why?
|
| Quality of Life | 2 | 2023 | 13461 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 4427 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2016 | 371 | 0.050 |
Why?
|
| Dioxygenases | 2 | 2014 | 354 | 0.050 |
Why?
|
| T-Box Domain Proteins | 2 | 2016 | 469 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2016 | 605 | 0.050 |
Why?
|
| Cyclin T | 1 | 2021 | 19 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2008 | 1341 | 0.050 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2003 | 332 | 0.050 |
Why?
|
| Selection Bias | 1 | 2023 | 361 | 0.050 |
Why?
|
| Gene Dosage | 3 | 2010 | 1216 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2009 | 3513 | 0.050 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2013 | 152 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1884 | 0.050 |
Why?
|
| Calcium Channels | 2 | 2017 | 622 | 0.050 |
Why?
|
| Genes, BRCA1 | 1 | 2004 | 750 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 1077 | 0.050 |
Why?
|
| Intention | 1 | 2024 | 346 | 0.040 |
Why?
|
| Asthma | 1 | 2020 | 6270 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2018 | 569 | 0.040 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2021 | 114 | 0.040 |
Why?
|
| Population Groups | 1 | 2021 | 209 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2017 | 1892 | 0.040 |
Why?
|
| RNA, Messenger | 4 | 2017 | 12769 | 0.040 |
Why?
|
| Platelet Aggregation | 1 | 2023 | 769 | 0.040 |
Why?
|
| Factor XIII | 1 | 2020 | 58 | 0.040 |
Why?
|
| Sweden | 2 | 2016 | 1381 | 0.040 |
Why?
|
| Motor Activity | 3 | 2016 | 2704 | 0.040 |
Why?
|
| Mifepristone | 1 | 2000 | 150 | 0.040 |
Why?
|
| Age Distribution | 2 | 2016 | 2858 | 0.040 |
Why?
|
| Prostate | 2 | 2022 | 1755 | 0.040 |
Why?
|
| Cross-Sectional Studies | 6 | 2020 | 26313 | 0.040 |
Why?
|
| Magnesium | 1 | 2023 | 813 | 0.040 |
Why?
|
| Connecticut | 2 | 2011 | 365 | 0.040 |
Why?
|
| Obesity, Abdominal | 1 | 2023 | 370 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 5696 | 0.040 |
Why?
|
| Genes, BRCA2 | 1 | 2023 | 588 | 0.040 |
Why?
|
| Corneal Diseases | 1 | 2005 | 535 | 0.040 |
Why?
|
| Netherlands | 1 | 2024 | 2277 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2011 | 247 | 0.040 |
Why?
|
| GTP-Binding Proteins | 2 | 2014 | 944 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2020 | 103 | 0.040 |
Why?
|
| Beer | 1 | 2019 | 134 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2019 | 198 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2020 | 65189 | 0.040 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2018 | 16 | 0.040 |
Why?
|
| Food | 2 | 2016 | 764 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2020 | 149 | 0.040 |
Why?
|
| Sleep | 1 | 2014 | 4812 | 0.040 |
Why?
|
| Wine | 1 | 2019 | 172 | 0.040 |
Why?
|
| DNA Repair Enzymes | 2 | 2012 | 342 | 0.040 |
Why?
|
| Germany | 1 | 2021 | 882 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2004 | 914 | 0.040 |
Why?
|
| Prevalence | 5 | 2016 | 15839 | 0.040 |
Why?
|
| Tonometry, Ocular | 1 | 2019 | 238 | 0.040 |
Why?
|
| DNA Mutational Analysis | 3 | 2017 | 4108 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 2018 | 194 | 0.040 |
Why?
|
| Diglycerides | 1 | 2018 | 174 | 0.040 |
Why?
|
| Women | 1 | 2020 | 226 | 0.040 |
Why?
|
| Hypoxanthine | 1 | 2018 | 28 | 0.040 |
Why?
|
| Cell Transplantation | 1 | 2000 | 473 | 0.040 |
Why?
|
| Comorbidity | 3 | 2023 | 10563 | 0.040 |
Why?
|
| Weight Gain | 1 | 2008 | 2355 | 0.040 |
Why?
|
| Receptors, Proteinase-Activated | 1 | 2017 | 18 | 0.040 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2019 | 245 | 0.040 |
Why?
|
| Educational Status | 2 | 2016 | 2513 | 0.040 |
Why?
|
| Phospholipase C beta | 1 | 2017 | 48 | 0.040 |
Why?
|
| Cause of Death | 2 | 2021 | 3708 | 0.040 |
Why?
|
| Telomere-Binding Proteins | 1 | 2018 | 122 | 0.040 |
Why?
|
| Fasting | 2 | 2017 | 1606 | 0.040 |
Why?
|
| Trans-Activators | 2 | 2008 | 2850 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 4850 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 680 | 0.040 |
Why?
|
| Disease-Free Survival | 4 | 2015 | 6832 | 0.040 |
Why?
|
| Synaptophysin | 1 | 2017 | 137 | 0.040 |
Why?
|
| Vocabulary | 1 | 2018 | 165 | 0.040 |
Why?
|
| Tea | 1 | 2019 | 290 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 2023 | 1146 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2018 | 126 | 0.040 |
Why?
|
| Ovarian Follicle | 1 | 2019 | 243 | 0.040 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2017 | 122 | 0.040 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 130 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2003 | 1325 | 0.040 |
Why?
|
| Calcifediol | 1 | 2018 | 156 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2009 | 533 | 0.040 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2020 | 272 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 661 | 0.040 |
Why?
|
| Lymphokines | 1 | 2000 | 911 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2000 | 624 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 2020 | 2817 | 0.030 |
Why?
|
| Inosine | 1 | 2018 | 129 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2016 | 1151 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5753 | 0.030 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1998 | 166 | 0.030 |
Why?
|
| Workflow | 1 | 2022 | 862 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 1999 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 2018 | 162 | 0.030 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2016 | 6 | 0.030 |
Why?
|
| Microvascular Angina | 1 | 1996 | 14 | 0.030 |
Why?
|
| Fanconi Anemia | 1 | 2019 | 327 | 0.030 |
Why?
|
| Base Sequence | 3 | 2019 | 12403 | 0.030 |
Why?
|
| Sweetening Agents | 1 | 2019 | 291 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2019 | 81515 | 0.030 |
Why?
|
| Canada | 1 | 2022 | 2119 | 0.030 |
Why?
|
| Cyclophilins | 1 | 2016 | 47 | 0.030 |
Why?
|
| Aconitic Acid | 1 | 2016 | 13 | 0.030 |
Why?
|
| Isocitrates | 1 | 2016 | 23 | 0.030 |
Why?
|
| Sudan | 1 | 2016 | 86 | 0.030 |
Why?
|
| tRNA Methyltransferases | 1 | 2016 | 50 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 1874 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 2 | 2015 | 1612 | 0.030 |
Why?
|
| Histones | 2 | 2017 | 2584 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 2 | 2012 | 999 | 0.030 |
Why?
|
| Simvastatin | 1 | 2018 | 345 | 0.030 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 18294 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 3421 | 0.030 |
Why?
|
| Oxidative Stress | 3 | 2015 | 3141 | 0.030 |
Why?
|
| Asia | 1 | 2017 | 628 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 8728 | 0.030 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2020 | 479 | 0.030 |
Why?
|
| Porphyrins | 1 | 2018 | 351 | 0.030 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2015 | 26 | 0.030 |
Why?
|
| Chemokines | 1 | 2020 | 956 | 0.030 |
Why?
|
| Child, Preschool | 6 | 2016 | 42500 | 0.030 |
Why?
|
| Muscles | 1 | 2000 | 1578 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 328 | 0.030 |
Why?
|
| Translocation, Genetic | 2 | 1998 | 1394 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2000 | 1216 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2016 | 10729 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2003 | 2599 | 0.030 |
Why?
|
| Mice, Knockout | 3 | 2016 | 14447 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2016 | 405 | 0.030 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2014 | 32 | 0.030 |
Why?
|
| Alcoholism | 1 | 2005 | 1975 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2017 | 8278 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 286 | 0.030 |
Why?
|
| Coffee | 1 | 2019 | 593 | 0.030 |
Why?
|
| Atlases as Topic | 1 | 2016 | 247 | 0.030 |
Why?
|
| Myoblasts | 1 | 2015 | 234 | 0.030 |
Why?
|
| Smell | 1 | 2016 | 259 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 1745 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2015 | 212 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 17594 | 0.030 |
Why?
|
| Finland | 1 | 2016 | 608 | 0.030 |
Why?
|
| Receptors, GABA-B | 1 | 2014 | 59 | 0.030 |
Why?
|
| Purines | 1 | 2018 | 615 | 0.030 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2001 | 1727 | 0.030 |
Why?
|
| Serpins | 1 | 2016 | 245 | 0.030 |
Why?
|
| Blood Coagulation Factors | 1 | 2016 | 371 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 592 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 2015 | 381 | 0.030 |
Why?
|
| Dynamin II | 1 | 2014 | 35 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 708 | 0.030 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 56 | 0.030 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 56 | 0.030 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 2659 | 0.030 |
Why?
|
| Receptor, Endothelin B | 1 | 2014 | 46 | 0.030 |
Why?
|
| Chromatin | 2 | 2018 | 2980 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2014 | 89 | 0.030 |
Why?
|
| Mathematical Computing | 1 | 2014 | 143 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 545 | 0.030 |
Why?
|
| Child Mortality | 1 | 2016 | 204 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 369 | 0.030 |
Why?
|
| ets-Domain Protein Elk-4 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 229 | 0.030 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2014 | 238 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 804 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 618 | 0.030 |
Why?
|
| Public Policy | 1 | 1998 | 551 | 0.030 |
Why?
|
| Liver | 3 | 2018 | 7562 | 0.030 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2013 | 10 | 0.030 |
Why?
|
| Eye Color | 1 | 2013 | 35 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 2033 | 0.030 |
Why?
|
| Denmark | 1 | 2016 | 774 | 0.030 |
Why?
|
| Vitamins | 2 | 2012 | 1630 | 0.030 |
Why?
|
| Dynamins | 1 | 2014 | 138 | 0.030 |
Why?
|
| Mothers | 1 | 2004 | 2208 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 1053 | 0.030 |
Why?
|
| Proinsulin | 1 | 2013 | 135 | 0.030 |
Why?
|
| Eye | 1 | 2017 | 710 | 0.030 |
Why?
|
| DNA, Neoplasm | 2 | 2009 | 1742 | 0.030 |
Why?
|
| Intelligence | 1 | 2018 | 923 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2000 | 1375 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2015 | 784 | 0.030 |
Why?
|
| Xanthophylls | 1 | 2012 | 95 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 453 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 2017 | 4778 | 0.030 |
Why?
|
| Angiogenic Proteins | 1 | 2013 | 101 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 1740 | 0.030 |
Why?
|
| Neuromyelitis Optica | 1 | 2016 | 266 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2013 | 295 | 0.030 |
Why?
|
| Nails | 1 | 2014 | 298 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 762 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 2012 | 190 | 0.020 |
Why?
|
| Lutein | 1 | 2012 | 123 | 0.020 |
Why?
|
| Trichomonas vaginalis | 1 | 2012 | 70 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 163 | 0.020 |
Why?
|
| Inhibins | 1 | 2012 | 211 | 0.020 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 3685 | 0.020 |
Why?
|
| Vegetables | 1 | 2017 | 1200 | 0.020 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2012 | 113 | 0.020 |
Why?
|
| Mexico | 1 | 2014 | 777 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 1119 | 0.020 |
Why?
|
| Exons | 2 | 2008 | 2391 | 0.020 |
Why?
|
| SOX9 Transcription Factor | 1 | 2012 | 146 | 0.020 |
Why?
|
| Piperidines | 1 | 2000 | 1664 | 0.020 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2012 | 145 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 323 | 0.020 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 146 | 0.020 |
Why?
|
| Diet, Mediterranean | 1 | 2018 | 746 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2018 | 1530 | 0.020 |
Why?
|
| Exosomes | 1 | 2016 | 421 | 0.020 |
Why?
|
| Calibration | 1 | 2014 | 814 | 0.020 |
Why?
|
| Reaction Time | 1 | 2018 | 2086 | 0.020 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2011 | 28 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 5389 | 0.020 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2011 | 30 | 0.020 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 1003 | 0.020 |
Why?
|
| Thymidylate Synthase | 1 | 2011 | 73 | 0.020 |
Why?
|
| Pakistan | 1 | 2012 | 300 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2016 | 1965 | 0.020 |
Why?
|
| DNA Primase | 1 | 2012 | 110 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2476 | 0.020 |
Why?
|
| Work | 1 | 2012 | 195 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1599 | 0.020 |
Why?
|
| Luciferases | 1 | 2013 | 713 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2012 | 368 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2012 | 404 | 0.020 |
Why?
|
| beta Carotene | 1 | 2012 | 522 | 0.020 |
Why?
|
| Androgens | 2 | 2011 | 1279 | 0.020 |
Why?
|
| Models, Animal | 1 | 2017 | 2120 | 0.020 |
Why?
|
| Progestins | 1 | 2013 | 300 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2021 | 2554 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2014 | 707 | 0.020 |
Why?
|
| Antilymphocyte Serum | 1 | 1992 | 493 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2009 | 5197 | 0.020 |
Why?
|
| Life Change Events | 1 | 2016 | 954 | 0.020 |
Why?
|
| Religion | 1 | 2014 | 376 | 0.020 |
Why?
|
| Benzyl Compounds | 2 | 1980 | 19 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2012 | 191 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2017 | 3089 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 595 | 0.020 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2010 | 116 | 0.020 |
Why?
|
| Boron Compounds | 1 | 2012 | 196 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
| Pigmentation | 1 | 2011 | 143 | 0.020 |
Why?
|
| Research Report | 1 | 2013 | 367 | 0.020 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2010 | 152 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2012 | 340 | 0.020 |
Why?
|
| Gene Deletion | 2 | 2009 | 2666 | 0.020 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2010 | 103 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 697 | 0.020 |
Why?
|
| Glycosyltransferases | 1 | 2010 | 114 | 0.020 |
Why?
|
| Piperazines | 1 | 2000 | 2549 | 0.020 |
Why?
|
| Cyprus | 1 | 2010 | 96 | 0.020 |
Why?
|
| Somatomedins | 1 | 2010 | 177 | 0.020 |
Why?
|
| Samoa | 1 | 2009 | 5 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 1123 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 2 | 1980 | 360 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 116 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2023 | 3837 | 0.020 |
Why?
|
| Caspase 10 | 1 | 2009 | 3 | 0.020 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 3430 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 2035 | 0.020 |
Why?
|
| Glucose | 2 | 2012 | 4335 | 0.020 |
Why?
|
| Lymphoma, T-Cell | 1 | 1992 | 309 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 990 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2010 | 187 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 1072 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1727 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2010 | 175 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2017 | 1263 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2015 | 1349 | 0.020 |
Why?
|
| North America | 1 | 2013 | 1285 | 0.020 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2009 | 75 | 0.020 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2009 | 88 | 0.020 |
Why?
|
| Adolescent Development | 1 | 2012 | 275 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 1731 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 1180 | 0.020 |
Why?
|
| Integrins | 1 | 2013 | 840 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2011 | 222 | 0.020 |
Why?
|
| Proprotein Convertases | 1 | 2009 | 95 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 1889 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 482 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1998 | 1560 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2013 | 1525 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3067 | 0.020 |
Why?
|
| Hyperthermia, Induced | 1 | 1992 | 415 | 0.020 |
Why?
|
| DNA Modification Methylases | 1 | 2009 | 207 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2016 | 2739 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2014 | 1154 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2008 | 56 | 0.020 |
Why?
|
| Interleukin-16 | 1 | 2008 | 34 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 507 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1992 | 791 | 0.020 |
Why?
|
| Education | 1 | 2011 | 533 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2016 | 4015 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2011 | 791 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2009 | 423 | 0.020 |
Why?
|
| Pain | 1 | 2023 | 5077 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 2010 | 390 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 4348 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 2007 | 151 | 0.020 |
Why?
|
| Reference Standards | 1 | 2011 | 1013 | 0.020 |
Why?
|
| Thrombophilia | 1 | 2010 | 308 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 2013 | 1006 | 0.020 |
Why?
|
| Calcium Channels, T-Type | 1 | 2007 | 28 | 0.020 |
Why?
|
| Betaine-Homocysteine S-Methyltransferase | 1 | 2007 | 6 | 0.020 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2007 | 12 | 0.020 |
Why?
|
| India | 1 | 2014 | 2334 | 0.020 |
Why?
|
| Transcobalamins | 1 | 2007 | 22 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 2942 | 0.020 |
Why?
|
| Nicotine | 1 | 2012 | 682 | 0.020 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2007 | 58 | 0.020 |
Why?
|
| Infant | 4 | 2016 | 36385 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15543 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2001 | 5343 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2009 | 409 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 238 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2008 | 265 | 0.020 |
Why?
|
| Social Class | 1 | 2016 | 2007 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1192 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 2825 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2023 | 4736 | 0.020 |
Why?
|
| Substance-Related Disorders | 2 | 2016 | 4415 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2015 | 18973 | 0.020 |
Why?
|
| Data Mining | 1 | 2011 | 562 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2010 | 578 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 499 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1761 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2012 | 852 | 0.020 |
Why?
|
| Health Occupations | 1 | 2008 | 226 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2014 | 8067 | 0.020 |
Why?
|
| Lipolysis | 1 | 2007 | 211 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 633 | 0.020 |
Why?
|
| Genes, ras | 1 | 2009 | 658 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 1997 | 7836 | 0.020 |
Why?
|
| Seasons | 1 | 2012 | 1524 | 0.020 |
Why?
|
| New Hampshire | 1 | 2006 | 174 | 0.020 |
Why?
|
| Karyotyping | 2 | 1998 | 1178 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2011 | 12437 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4562 | 0.020 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2007 | 271 | 0.020 |
Why?
|
| DNA Damage | 1 | 2015 | 2457 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2019 | 3242 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2011 | 1078 | 0.020 |
Why?
|
| Mitochondria | 1 | 2019 | 3673 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2005 | 31 | 0.020 |
Why?
|
| Los Angeles | 1 | 2006 | 244 | 0.020 |
Why?
|
| Stochastic Processes | 1 | 2007 | 358 | 0.020 |
Why?
|
| Color | 1 | 2006 | 299 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 4908 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 932 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2015 | 5881 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 7122 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2010 | 2263 | 0.010 |
Why?
|
| Sunburn | 1 | 2006 | 156 | 0.010 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2009 | 565 | 0.010 |
Why?
|
| Dietary Fiber | 1 | 2009 | 767 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 5501 | 0.010 |
Why?
|
| Spermatogenesis | 1 | 2006 | 260 | 0.010 |
Why?
|
| Sunlight | 1 | 2006 | 337 | 0.010 |
Why?
|
| Diet Surveys | 1 | 2008 | 1159 | 0.010 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2009 | 904 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 1394 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2005 | 215 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2845 | 0.010 |
Why?
|
| Anthropometry | 1 | 2008 | 1338 | 0.010 |
Why?
|
| Apoptosis | 1 | 2020 | 9514 | 0.010 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2003 | 41 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7425 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 869 | 0.010 |
Why?
|
| Radiography | 1 | 2014 | 6919 | 0.010 |
Why?
|
| Ataxia Telangiectasia | 1 | 2004 | 107 | 0.010 |
Why?
|
| Adult Children | 1 | 2003 | 104 | 0.010 |
Why?
|
| Cadherins | 1 | 2008 | 900 | 0.010 |
Why?
|
| Leucine | 1 | 2004 | 546 | 0.010 |
Why?
|
| Dust | 1 | 2006 | 489 | 0.010 |
Why?
|
| Immunophenotyping | 2 | 1998 | 1866 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2013 | 2966 | 0.010 |
Why?
|
| Information Dissemination | 1 | 2011 | 1142 | 0.010 |
Why?
|
| Hair | 1 | 2006 | 508 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2005 | 602 | 0.010 |
Why?
|
| Nitrogen Dioxide | 1 | 2006 | 538 | 0.010 |
Why?
|
| Skin | 1 | 2016 | 4489 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 1995 | 0.010 |
Why?
|
| Carbon Monoxide | 1 | 2006 | 560 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2003 | 209 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 1167 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 2067 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11022 | 0.010 |
Why?
|
| New England | 1 | 2005 | 1059 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2017 | 3458 | 0.010 |
Why?
|
| Health Behavior | 1 | 2013 | 2650 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9373 | 0.010 |
Why?
|
| Emotions | 1 | 2013 | 2763 | 0.010 |
Why?
|
| Adipocytes | 1 | 2008 | 1194 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2010 | 2113 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 1996 | 4533 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 1718 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2006 | 1102 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 3737 | 0.010 |
Why?
|
| Levonorgestrel | 1 | 2000 | 76 | 0.010 |
Why?
|
| Public Health | 1 | 2013 | 2680 | 0.010 |
Why?
|
| Lac Operon | 1 | 2000 | 238 | 0.010 |
Why?
|
| Densitometry | 1 | 1980 | 150 | 0.010 |
Why?
|
| Rats | 3 | 1981 | 23707 | 0.010 |
Why?
|
| Ovulation | 1 | 2000 | 178 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2000 | 461 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 413 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1981 | 2077 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 6493 | 0.010 |
Why?
|
| Autoradiography | 1 | 1980 | 723 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 6113 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 2006 | 1470 | 0.010 |
Why?
|
| Drug Compounding | 1 | 2000 | 235 | 0.010 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2009 | 2054 | 0.010 |
Why?
|
| Internet | 1 | 2011 | 3106 | 0.010 |
Why?
|
| Pyridazines | 1 | 2000 | 200 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2446 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2019 | 6851 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2005 | 1481 | 0.010 |
Why?
|
| Overweight | 1 | 2010 | 2443 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 1992 | 3310 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2000 | 682 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2000 | 308 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 754 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 2000 | 907 | 0.010 |
Why?
|
| Boston | 1 | 2011 | 9338 | 0.010 |
Why?
|
| Endometrium | 1 | 2000 | 406 | 0.010 |
Why?
|
| Life Tables | 1 | 1998 | 363 | 0.010 |
Why?
|
| Cytogenetics | 1 | 1998 | 198 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2000 | 854 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2000 | 1752 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1980 | 2266 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 8871 | 0.010 |
Why?
|
| Brain | 2 | 2016 | 27178 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2001 | 804 | 0.010 |
Why?
|
| Myocardium | 1 | 2008 | 4760 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1998 | 498 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2000 | 2630 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5337 | 0.010 |
Why?
|
| Rabbits | 1 | 2000 | 4734 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15880 | 0.010 |
Why?
|
| Critical Care | 1 | 2007 | 2712 | 0.010 |
Why?
|
| Feces | 1 | 1980 | 1504 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2011 | 11640 | 0.010 |
Why?
|
| Macrophages | 1 | 2008 | 5772 | 0.010 |
Why?
|
| Cell Division | 1 | 2000 | 4475 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1992 | 283 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2000 | 2844 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 36532 | 0.010 |
Why?
|
| Protein Binding | 1 | 2000 | 9296 | 0.000 |
Why?
|
| Myocardial Ischemia | 1 | 1996 | 2128 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1992 | 1433 | 0.000 |
Why?
|
| Kidney | 1 | 1980 | 7066 | 0.000 |
Why?
|
| Transplantation, Homologous | 1 | 1992 | 4860 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1992 | 4499 | 0.000 |
Why?
|